Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Department of Neurosurgery, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.
Br J Neurosurg. 2023 Feb;37(1):26-34. doi: 10.1080/02688697.2020.1859089. Epub 2020 Dec 26.
Insular gliomas are unique, challenging and evoke a lot of interest amongst neurosurgeons. Publications on insular glioma generally focus on the surgical intricacies and extent of resection pertaining to the low-grade gliomas. Insular glioblastomas (iGBM) have not been analysed separately before.
Histologically proven WHO grade IV gliomas involving the insula over a 9-year period were studied. Their clinical presentation, radiological features, surgical findings and survival outcomes were assessed. Statistical methods were used to determine the favourable predictors of survival.
Out of 27 patients (M:F = 2.9:1), 18 (66%) patients had a tumour extension beyond the insula, 10 (37%) of whom had basal ganglia involvement. Total, near total and subtotal excisions were performed in 7 (26%), 9 (33%) and 11 (40.7%) patients, respectively. Twenty-three patients had glioblastoma, while four had gliosarcoma. IDH mutation was negative in six of the seven patients where it was done. Median overall survival was 5 months. Multivariate analysis showed that a female gender ( = 0.013), seizures in the preoperative period ( = 0.048) and completion of adjuvant therapy ( = 0.003) were associated with a longer survival.
Insular glioblastomas have a poor prognosis. Insular location and certain tumour characteristics often limit the extent of resection of iGBMs. Moreover, postoperative complications sometimes negate the advantages of a radical resection. A female gender, presentation with seizures and completion of adjuvant chemoradiotherapy appear to be good prognostic factors.
岛叶胶质瘤是一种独特且具有挑战性的肿瘤,引起了神经外科医生的极大兴趣。关于岛叶胶质瘤的出版物通常侧重于低级别胶质瘤的手术复杂性和切除范围。以前没有单独分析过岛叶胶质母细胞瘤(iGBM)。
研究了过去 9 年中经组织学证实的累及岛叶的 IV 级胶质瘤患者。评估了他们的临床表现、影像学特征、手术发现和生存结果。使用统计方法确定了生存的有利预测因素。
在 27 名患者中(男:女=2.9:1),18 名(66%)患者的肿瘤延伸超出了岛叶,其中 10 名(37%)患者的肿瘤侵犯了基底节。7 名(26%)、9 名(33%)和 11 名(40.7%)患者分别进行了全切除、近全切除和次全切除。23 名患者患有胶质母细胞瘤,4 名患者患有胶质肉瘤。在进行 IDH 突变检测的 7 名患者中,有 6 名患者的 IDH 突变呈阴性。中位总生存期为 5 个月。多变量分析显示,女性性别(=0.013)、术前癫痫发作(=0.048)和辅助治疗完成(=0.003)与更长的生存时间相关。
岛叶胶质母细胞瘤预后不良。岛叶的位置和某些肿瘤特征通常限制了 iGBM 的切除范围。此外,术后并发症有时会抵消根治性切除的优势。女性性别、癫痫发作和完成辅助放化疗似乎是良好的预后因素。